Showing results (1251-1260 of 1,339) with videos related to

Sort By:
Pageof 134
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2022
MicroRNA-29a attenuates CD8 T cell exhaustion and induces memory-like CD8 T cells during chronic infectionErietta Stelekati, Zhangying Cai, Sasikanth Manne, et al.
Genes & Diseases|September 28, 2018
Genetic diseases conferring resistance to infectious diseasesIsabelle C Withrock, Stephen J Anderson, Matthew A Jefferson, et al.
Journal of Medicinal Chemistry|January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activityK Leftheris, T Kline, G D Vite, et al.
Nature|July 21, 2017
Human occupation of northern Australia by 65,000 years agoChris Clarkson, Zenobia Jacobs, Ben Marwick, et al.
Journal of Medicinal Chemistry|August 12, 2008
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activitiesKyoung Soon Kim, Liping Zhang, Robert Schmidt, et al.
Nature Communications|March 7, 2015
Genomic landscape of paediatric adrenocortical tumoursEmilia M Pinto, Xiang Chen, John Easton, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Pageof 134